检索结果 - Ronit Simantov

Refine Results
  1. 1
    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 由 Ronit Simantov, Maria Febbraio, René Crombie, Adam S. Asch, Ralph L. Nachman, Roy L. Silverstein

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database 由 André P. Fay, Rana R. McKay, Xun Lin, Ronit Simantov, Toni K. Choueiri

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II

    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II 由 Keying Ma, Ronit Simantov, Jing-Chuan Zhang, Roy L. Silverstein, Katherine A. Hajjar, Keith R. McCrae

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma

    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma 由 Rana R. McKay, Xun Lin, Julia Jane Perkins, Daniel Y.C. Heng, Ronit Simantov, Toni K. Choueiri

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

    Activation of cultured vascular endothelial cells by antiphospholipid antibodies. 由 Ronit Simantov, J M LaSala, S K Lo, A E Gharavi, Lisa R. Sammaritano, Jane E. Salmon, Roy L. Silverstein

    出版 1995
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma

    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma 由 Viktor Grünwald, Rana R. McKay, Katherine M. Krajewski, D. Kalanovic, Xun Lin, Julia Jane Perkins, Ronit Simantov, Toni K. Choueiri

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo 由 Ling Qi, Andrew T. Jacovina, Arunkumar B. Deora, Maria Febbraio, Ronit Simantov, Roy L. Silverstein, Barbara Hempstead, Willie Mark, Katherine A. Hajjar

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma 由 Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole‐Petter R. Hamnvik, Venkata Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice

    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice 由 Hayes M. Dansky, Sherri A. Charlton, John L. Sikes, Simon Heath, Ronit Simantov, Lawrence F. Levin, Pei Shu, Karen J. Moore, Jan L. Breslow, Jonathan D. Smith

    出版 1999
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors

    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors 由 Igor Puzanov, Colin R. Lindsay, Laura W. Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T.R. Jeffry Evans

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer

    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer 由 Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph S. Marks, Joel R. Reid, Gary A. Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer

    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer 由 April A. N. Rose, Andrée‐Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia MacDonald, Nicholas Bertos, Yves St‐Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury, Peter M. Siegel

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors

    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors 由 Robin L. Jones, Edward S. Kim, Pilar Nava-Parada, Salma Alam, Faye M. Johnson, Andrew Stephens, Ronit Simantov, Srinivasu Poondru, Rich Gedrich, Scott M. Lippman, Stan B. Kaye, Craig P. Carden

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus

    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus 由 Mary J. Roman, Beth‐Ann Shanker, Adrienne Davis, Michael D. Lockshin, Lisa R. Sammaritano, Ronit Simantov, Mary K. Crow, Joseph E. Schwartz, Stephen A. Paget, Richard B. Devereux, Jane E. Salmon

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Statins and survival outcomes in patients with metastatic renal cell carcinoma

    Statins and survival outcomes in patients with metastatic renal cell carcinoma 由 Rana R. McKay, Xun Lin, Laurence Albigès, André P. Fay, Marina D. Kaymakcalan, Suzanne S Mickey, P. Peter Ghoroghchian, Rupal S. Bhatt, Samuel Kaffenberger, Ronit Simantov, Toni K. Choueiri, Daniel Yick Chin Heng

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma 由 Patrick A. Ott, Omid Hamid, Anna C. Pavlick, Harriet M. Kluger, Kevin B. Kim, Peter D. Boasberg, Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, Thomas A. Davis, Mario Sznol, Patrick Hwu

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer 由 Johanna C. Bendell, Mansoor N. Saleh, April A. N. Rose, Peter M. Siegel, Lowell L. Hart, Surendra Sirpal, Suzanne F. Jones, Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, Thomas A. Davis, Linda T. Vahdat

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis 由 Tim Eisen, T. Ahmad, Keith T. Flaherty, Martin Gore, Stan B. Kaye, Richard Marais, I. Gibbens, Samuel Hackett, Maggie James, Lynn M. Schuchter, Katherine L. Nathanson, Chenjing Xia, Ronit Simantov, Brian Schwartz, Melanie Poulin-Costello, Peter J. O’Dwyer, Mark J. Ratain

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma

    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma 由 Aly‐Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé, John A. Steinharter, Dylan J. Martini, Ronit Simantov, Xun Lin, Xiao X. Wei, Bradley A. McGregor, Rana R. McKay, Lauren C. Harshman, Toni K. Choueiri

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma 由 Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, M. Siebels, Sylvie Négrier, Christine Chevreau, E Solska, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sara M. Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M. Bukowski

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: